Last Updated: September 24, 2026

Details for New Drug Application (NDA): 217667

✉ Email this page to a colleague

« Back to Dashboard

NDA 217667 describes COLESTIPOL HYDROCHLORIDE, which is a drug marketed by Impax Labs, Ani Pharms, Edenbridge Pharms, Pharmobedient, Riconpharma Llc, and Zydus Pharms, and is included in seven NDAs. It is available from eight suppliers. Additional details are available on the COLESTIPOL HYDROCHLORIDE profile page.

The generic ingredient in COLESTIPOL HYDROCHLORIDE is colestipol hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

Summary for 217667

Tradename:	COLESTIPOL HYDROCHLORIDE
Applicant:	Edenbridge Pharms
Ingredient:	colestipol hydrochloride
Patents:	0

Pharmacology for NDA: 217667

Mechanism of Action	Bile-acid Binding Activity

Medical Subject Heading (MeSH) Categories for 217667

Anion Exchange Resins
Hypolipidemic Agents
Sequestering Agents

Suppliers and Packaging for NDA: 217667

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
COLESTIPOL HYDROCHLORIDE	colestipol hydrochloride	TABLET;ORAL	217667	ANDA	Edenbridge Pharmaceuticals LLC.	42799-115	42799-115-01	120 TABLET in 1 BOTTLE (42799-115-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	1GM
Approval Date:	Aug 16, 2024	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.